202 related articles for article (PubMed ID: 22336946)
21. In this issue: glycine substitution mutations in the COL7A1 gene: implications for inheritance of dystrophic epidermolysis bullosa - dominant vs. recessive.
Uitto J
Acta Derm Venereol; 2011 May; 91(3):259-61. PubMed ID: 21547333
[No Abstract] [Full Text] [Related]
22. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
[TBL] [Abstract][Full Text] [Related]
23. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
[TBL] [Abstract][Full Text] [Related]
24. A novel indel COL7A1 mutation 8068del17insGA causes dominant dystrophic epidermolysis bullosa.
Sawamura D; Nizeki H; Miyagawa S; Shinkuma S; Shimizu H
Br J Dermatol; 2006 May; 154(5):995-7. PubMed ID: 16634910
[No Abstract] [Full Text] [Related]
25. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
26. Fibroblasts as target cells for DEB gene therapy.
Chen M; Woodley DT
J Invest Dermatol; 2006 Apr; 126(4):708-10. PubMed ID: 16541096
[TBL] [Abstract][Full Text] [Related]
27. Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagen.
Frew J; Lim SW; Klausseger A; Chow CW; Tran K; Su J; Orchard D; Varigos G; Sawamura D; Nishie W; Shimizu H; Murrell DF
Australas J Dermatol; 2011 Nov; 52(4):e1-4. PubMed ID: 22070715
[TBL] [Abstract][Full Text] [Related]
28. Revertant mosaicism in recessive dystrophic epidermolysis bullosa.
Almaani N; Nagy N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Clements SE; Techanukul T; Tanaka A; Mellerio JE; McGrath JA
J Invest Dermatol; 2010 Jul; 130(7):1937-40. PubMed ID: 20357813
[No Abstract] [Full Text] [Related]
29. Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT).
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):65-6. PubMed ID: 24933565
[No Abstract] [Full Text] [Related]
30. A Case of Dominant Dystrophic Epidermolysis Bullosa Responding Well to an Old Medication.
Leung J; Kuzel P; Kurian A; Brassard A
JAMA Dermatol; 2015 Nov; 151(11):1264-5. PubMed ID: 26154424
[No Abstract] [Full Text] [Related]
31. Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa.
Izmiryan A; Danos O; Hovnanian A
J Invest Dermatol; 2016 Apr; 136(4):872-875. PubMed ID: 26897595
[No Abstract] [Full Text] [Related]
32. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation in recessive dystrophic epidermolysis bullosa: when missense doesn't make sense.
Wessagowit V; Kim SC; Woong Oh S; McGrath JA
J Invest Dermatol; 2005 Apr; 124(4):863-6. PubMed ID: 15816848
[No Abstract] [Full Text] [Related]
34. Recessive dystrophic epidermolysis bullosa: identification of a novel COL7A1 mutation of D44N.
Makino E; Nakano H; Sawamura D; Fujimoto W
J Dermatol Sci; 2012 Nov; 68(2):109-12. PubMed ID: 22854212
[No Abstract] [Full Text] [Related]
35. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy.
Gorell ES; Nguyen N; Siprashvili Z; Marinkovich MP; Lane AT
Br J Dermatol; 2015 Sep; 173(3):821-3. PubMed ID: 25703736
[No Abstract] [Full Text] [Related]
36. Compound Heterozygosity of Dominant and Recessive COL7A Alleles in a Severely Affected Patient with a Family History of Dystrophic Epidermolysis Bullosa: Clinical Findings, Genetic Testing, and Treatment Implications.
Watson KD; Schoch JJ; Beek GJ; Hand JL
Pediatr Dermatol; 2017 Mar; 34(2):166-171. PubMed ID: 28297147
[TBL] [Abstract][Full Text] [Related]
37. A Japanese family with dominant pretibial dystrophic epidermolysis bullosa: Identification of a new glycine substitution in the triple-helical collagenous domain of type VII collagen.
Hamada T; Fukuda S; Ishii N; Abe T; Nagata K; Koro O; Hatano Y; Nakano H; Sawamura D; Hashimoto T
J Dermatol Sci; 2009 Jun; 54(3):212-4. PubMed ID: 19269793
[No Abstract] [Full Text] [Related]
38. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
[TBL] [Abstract][Full Text] [Related]
39. Recessive bullous dermolysis of the newborn in preterm siblings with a missense mutation in type VII collagen.
Boccaletti V; Zambruno G; Castiglia D; Magnani C; Tognetti E; Fabrizi G; Cortelazzi C; Pagliarello C; Di Nuzzo S
Pediatr Dermatol; 2015; 32(2):e42-7. PubMed ID: 25639640
[TBL] [Abstract][Full Text] [Related]
40. Large Deletions Targeting the Triple-Helical Domain of Collagen VII Lead to Mild Acral Dominant Dystrophic Epidermolysis Bullosa.
Chmel N; Bornert O; Hausser I; Grüninger G; Borozkin W; Kohlhase J; Nyström A; Has C
J Invest Dermatol; 2018 Apr; 138(4):987-991. PubMed ID: 29179948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
